Close menu

January 31st, 2023 | 14:33 CET

This new project changes everything: Deutsche Bank, Aspermont, Alibaba

  • Digitization
  • Innovations
  • Technology
  • Investments
Photo credits:

When processes go digital, great opportunities arise: automation and scaling can ensure growth and turn established business models into high-flyers. But which companies should investors actively support in their transformation? Where is there real potential for investors, and where are companies just spreading buzzwords? We highlight three stocks for you.

time to read: 3 minutes | Author: Nico Popp

Table of contents:

    Deutsche Bank: How digital is the share?

    Deutsche Bank's share will be among the winners of 2023. Last month alone, the stock went up by around 11%. Over a six-month period, it has even risen by more than 45%. The reason for the share price rally is the interest rate turnaround. The higher the interest rates, the better banks can earn money with their bread-and-butter loans business. Investment banking also remained robust until the end - there was little sign of a crisis. But Deutsche Bank still has room for improvement in terms of returns. The solution to this problem is said to lie in ongoing digitization.

    Years ago, the Company announced it wanted to focus more on areas where it could offer customers the greatest added value. Digitization is to play a significant role in this. In this way, security is to increase, and costs are to decrease. In order to bring a breath of fresh air into the bank, Deutsche Bank already sought increased cooperation with startups a few years ago. Anyone logging into their account today will quickly find such offers - be it around interest solutions or in other areas. So Deutsche Bank is on the right track. However, the digitization strategy will not bring the big breakthrough for shareholders. The reason: Deutsche Bank is too big and sluggish for individual projects to make such a big impact. However, the share remains solid.

    Aspermont: Digital financing platform exceeds expectations

    The Australian mediatech company Aspermont is more than solidly positioned. The Company comes from the traditional publishing business and stands, among others, for the renowned brands Mining Journal and Mining Magazine. In addition, Aspermont offers numerous other solutions for farmers, industrial companies and customers from the raw materials sector. A few years ago, Aspermont launched its digitization strategy and now rolls out its content predominantly digitally. The business relationships accumulated over decades are now also paying off in the event business, which Aspermont is driving both in physical presence and digitally. In 2022, Aspermont launched Blu Horseshoe, a financing platform with renowned partners, which has already processed 118 transactions in the first four months of its existence.

    The Company sees this development as trend-setting. The digital platform is likely to be implementable in other markets as well. Proof that there is a market for such solutions has been provided. Coupled with the attractive media business, trade shows and other events, Aspermont offers comprehensive solutions for companies in the commodities sector and for growth companies in general. The research portal currently sees the stock as attractive: "The price-to-sales ratio of 3 with organic sales growth of 20% and margins of over 50% compares favorably with the peer group," according to the latest report.

    Innovation is a top priority at Deutsche Bank. Photo: Deutsche Bank

    Alibaba: End of the line?

    The success of Alibaba, among others, shows that it can pay off to advance several synergistic and, at the same time, digital business areas. In addition to eCommerce and auctions, the Company also indirectly offers payment services, cloud solutions and all kinds of other projects. Customers can, therefore, hardly avoid Alibaba. Especially in China, the Company is strong and generates almost 70% of its sales. Due to the pandemic, economic activity in China weakened in 2022. Alibaba also felt the impact - for the first time in years, the Company did not publish full sales results for Singles Day. The eCommerce giant and Amazon clone also failed to provide a detailed outlook for 2023. The stock gained after the turn of the year but is currently consolidating. Even a share buyback program cannot stabilize the share price at present. In the long term, there is potential here, but in the short term, it can become turbulent.

    Things look much more relaxed at mediatech hopeful Aspermont - the share price has been fixed around EUR 0.013 for months. This boredom can be a solid starting point for all investors convinced of the scaling story at Aspermont. For stocks such as Deutsche Bank and Alibaba, the drop seems more significant, given recent gains. Aspermont is also worth closer analysis for investors who otherwise tend to back blue chips.

    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.

    Der Autor

    Nico Popp

    At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

    About the author

    Related comments:

    Commented by Juliane Zielonka on September 29th, 2023 | 07:00 CEST

    Defence Therapeutics, Schott Pharma, Allianz Group: Focus on Innovation, Growth and Portfolio Optimization

    • Biotechnology
    • Pharma
    • Investments

    According to a recent study, biotech company Defence Therapeutics achieves twice the immune response of conventional mRNA therapies with its Accum® mRNA technology. That translates to fewer side effects and a more effective treatment. According to Precedence Research, the market size for mRNA therapeutics is projected to reach approximately USD 137.59 billion by 2032. It is expected to grow at a CAGR of 13.2% from 2023 to 2032. In order to inject these active ingredients, precision-fit medical vials are required, and Schott Pharma is ensuring this with their IPO launched on the German stock exchange this week, which could bring a valuation of around EUR 4 billion. The Allianz Group, on the other hand, is focusing on consolidation, selling its business in the Middle East and thus flushing around EUR 210 million cash into its coffers.


    Commented by Stefan Feulner on September 27th, 2023 | 08:30 CEST

    AI shares in focus:, Norcom, Amazon - Upgrade at any cost

    • Software
    • AI
    • Technology

    The implementation of generative artificial intelligence on a large scale has the potential to significantly boost the German economy, according to a study by IW Consult, conducted on behalf of Google. In this context, the comprehensive integration of programs such as ChatGPT by at least half of domestic companies could increase economic output by around EUR 330 billion. This value corresponds to almost 10% of the German gross domestic product of the previous year. This is likely to herald a quantum leap for providers of intelligent software.


    Commented by André Will-Laudien on September 27th, 2023 | 08:05 CEST

    The high-tech gold rush on the Nasdaq is waning: BYD, Manuka Resources, and Infineon remain on the buy list

    • Mining
    • Vanadium
    • Electromobility
    • Technology
    • GreenTech

    For those investing in green or high-tech sectors, keeping an eye on the supply chains of raw materials is crucial. After all, in times of geopolitical upheaval, nothing seems more important to the industry than securing its foreign sources of critical resources. The EU and the US have already responded by adding several metals to the list of strategic elements. For the capital markets, too, the fight against global warming has become an issue that cannot be ignored. We focus on successful protagonists that can enhance any portfolio.